OUR BLOG
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
See all Ideas & Insights
Tr1X, Inc. Announces $75 Million Series A Financing
Article by
PR Newswire
•
Jan 22, 2024
Our Clients

Tr1X, Inc. Announces $75 Million Series A Financing
Article by
PR Newswire
•
Jan 22, 2024
Our Clients

Lucid Link has raised $75 million in a venture round
Article by
TechCrunch
•
Dec 6, 2023
Our Clients
.avif)
Lucid Link has raised $75 million in a venture round
Article by
TechCrunch
•
Dec 6, 2023
Our Clients
.avif)
BioLoomics Raises $8.7 Million Seed Round to Develop Target Degrading Antibodies
Article by
Business Wire
•
Sep 20, 2023
Our Clients
.avif)
BioLoomics Raises $8.7 Million Seed Round to Develop Target Degrading Antibodies
Article by
Business Wire
•
Sep 20, 2023
Our Clients
.avif)
Ameelio Named One of Time’s 100 Most Influential Companies of 2023
Article by
Ameelio
•
Aug 2, 2023
Our Clients
.avif)
Ameelio Named One of Time’s 100 Most Influential Companies of 2023
Article by
Ameelio
•
Aug 2, 2023
Our Clients
.avif)
Preparing teams for branding: Wunderdogs’ guide to agency selection and project success
Article by
Daria Gonzalez
•
Apr 14, 2023
Media

Preparing teams for branding: Wunderdogs’ guide to agency selection and project success
Article by
Daria Gonzalez
•
Apr 14, 2023
Media

Candidly Raises $20.5 Million to Help Millions of Americans Repay Student Debt and Build Savings
Article by
Businesswire
•
Mar 7, 2023
Our Clients

Candidly Raises $20.5 Million to Help Millions of Americans Repay Student Debt and Build Savings
Article by
Businesswire
•
Mar 7, 2023
Our Clients

'As the market has turned': Enveda secures $68M to move revised pipeline into the clinic in 2023
Article by
Endpoints News
•
Dec 21, 2022
Our Clients

'As the market has turned': Enveda secures $68M to move revised pipeline into the clinic in 2023
Article by
Endpoints News
•
Dec 21, 2022
Our Clients

Entact Bio makes its Series A debut with $81M to launch protein enhancement platform
Article by
Endpoints News
•
Nov 8, 2022
Our Clients

Entact Bio makes its Series A debut with $81M to launch protein enhancement platform
Article by
Endpoints News
•
Nov 8, 2022
Our Clients
